When does the Sucraid (sacrosidase) patent expire?
The specific patent expiration date for Sucraid depends on which patent and jurisdiction you mean (for example, a primary compound patent vs. related formulation, method-of-use, or exclusivity periods). With the information provided here, the exact patent expiry date for Sucraid cannot be confirmed.
What should you check to get the exact expiration date?
To determine the correct expiration, you generally need the patent number (or a brand-to-patent mapping) and then look up the expiry rules for that patent in the relevant country, since:
- Some patents expire based on their filing date (with possible adjustments).
- Regulatory exclusivity (separate from patent term) can delay generic entry even after patent expiry.
- There can be multiple overlapping patents; the “last to expire” one typically matters for market exclusivity.
Where can you look up Sucraid’s patent expiry?
Common sources include:
- FDA Orange Book (U.S.) for patents and exclusivity listed for Sucraid
- Patent databases in the relevant jurisdiction (for example, USPTO for U.S. patents)
If you tell me the country (e.g., U.S.) or share the patent number you’re looking at, I can help you pinpoint the exact expiration date and what it applies to.
How long until generics or biosimilars can enter after expiry?
Generic versions generally can’t enter until the relevant patents and any listed regulatory exclusivities have expired or been cleared. Without the specific patent list and jurisdiction, it’s not possible to translate “patent expiry” into an exact “generic launch date” for Sucraid.
Quick question to narrow it down
Do you mean the patent expiry in the United States (FDA Orange Book), or another country? If you share the patent number, I can give you the precise expiration date.